The cytoplasmic precursor of CLU binds to ROCK1, reducing the phosphorylation of ERK1/2 by suppressing the kinase activity of ROCK1 and thereby disrupting the connection between ROCK1 and ERK, therefore hindering ERK activity and reducing lung cancer’s ability to invade. The gene discussed is ROCK1; the disease is lung carcinoma.